Literature DB >> 26305023

Prognostic Impact of Visceral Fat Amount and Branched-Chain Amino Acids (BCAA) in Hepatocellular Carcinoma.

Takaaki Higashi1, Hiromitsu Hayashi1, Takayoshi Kaida1, Kota Arima1, Hideaki Takeyama1, Katsunobu Taki1, Daisuke Izumi1, Ryuma Tokunaga1, Keisuke Kosumi1, Shigeki Nakagawa1, Hirohisa Okabe1, Katsunobu Imai1, Hidetoshi Nitta1, Daisuke Hashimoto1, Akira Chikamoto1, Toru Beppu1, Hideo Baba2.   

Abstract

BACKGROUND: Dysregulation of lipid and amino acid metabolism in patients with liver diseases results in obesity-related carcinogenesis and decreased levels of branched-chain amino acids (BCAA), respectively. This study assessed the clinical and prognostic impact of visceral fat amount (VFA) and its association with amino acid metabolism in patients with hepatocellular carcinoma (HCC).
METHODS: In this study, 215 patients who underwent hepatic resection for HCC were divided into two groups based on VFA criteria for metabolic abnormalities in Japan. Computed tomography was used to measure VFA at the third lumbar vertebra in the inferior direction.
RESULTS: Of the 215 patients, 132 had high and 83 had low VFA. High VFA was significantly associated with older age and higher body mass index (BMI), subcutaneous fat amount, and BCAA, but not with liver function, nutrient status, or tumoral factors. VFA was positively correlated with BMI (P < 0.0001; r = 0.63) and BCAA levels (P < 0.0001; r = 0.29). Overall survival was significantly greater in the high than in the low VFA group (P = 0.002). Multivariate analyses showed that high VFA [hazard ratio (HR) 7.06; P = 0.024] and neutrophil/lymphocyte ratio (HR 3.47; P = 0.049) were significantly prognostic of overall survival, whereas subcutaneous fat amount, BMI, BCAA, serum albumin, and prognostic nutritional index were not.
CONCLUSIONS: High VFA was associated with a high BCAA level, with high VFA prognostic of improved overall survival in Japanese patients with HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26305023     DOI: 10.1245/s10434-015-4796-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

Review 1.  Adiposity and cancer survival: a systematic review and meta-analysis.

Authors:  Elizabeth M Cespedes Feliciano; Bette J Caan; En Cheng; Jocelyn Kirley
Journal:  Cancer Causes Control       Date:  2022-08-15       Impact factor: 2.532

Review 2.  Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis.

Authors:  Deirdre K Tobias; Samia Mora; Subodh Verma; Patrick R Lawler
Journal:  Curr Opin Cardiol       Date:  2018-09       Impact factor: 2.161

Review 3.  Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.

Authors:  Xingshun Qi; Jianjun Li; Han Deng; Hongyu Li; Chunping Su; Xiaozhong Guo
Journal:  Oncotarget       Date:  2016-07-19

4.  Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma.

Authors:  Elitsa A Ananieva; Joshua N Bostic; Ashley A Torres; Hannah R Glanz; Sean M McNitt; Michelle K Brenner; Michael P Boyer; Adele K Addington; Susan M Hutson
Journal:  Br J Cancer       Date:  2018-10-15       Impact factor: 7.640

5.  No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.

Authors:  Issei Saeki; Takahiro Yamasaki; Masaki Maeda; Reo Kawano; Takuro Hisanaga; Takuya Iwamoto; Toshihiko Matsumoto; Isao Hidaka; Tsuyoshi Ishikawa; Taro Takami; Isao Sakaida
Journal:  Liver Cancer       Date:  2018-04-06       Impact factor: 11.740

6.  Changes of Branched-Chain Amino Acids and Ectopic Fat in Response to Weight-loss Diets: the POUNDS Lost Trial.

Authors:  Xiang Li; Dianjianyi Sun; Tao Zhou; Hao Ma; Yoriko Heianza; Zhaoxia Liang; George A Bray; Frank M Sacks; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

7.  An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.

Authors:  Lu Ao; Xuekun Song; Xiangyu Li; Mengsha Tong; You Guo; Jing Li; Hongdong Li; Hao Cai; Mengyao Li; Qingzhou Guan; Haidan Yan; Zheng Guo
Journal:  Oncotarget       Date:  2016-04-26

Review 8.  Branched-chain amino acid metabolism in cancer.

Authors:  Elitsa A Ananieva; Adam C Wilkinson
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-01       Impact factor: 4.294

9.  Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment.

Authors:  Kenji Imai; Koji Takai; Toshihide Maeda; Satoshi Watanabe; Tatsunori Hanai; Atsushi Suetsugu; Makoto Shiraki; Masahito Shimizu
Journal:  Oncotarget       Date:  2018-02-16

10.  Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy.

Authors:  Satoshi Yamagiwa; Takamasa Kobayashi; Hirokazu Kawai; Oki Nakano; Satoshi Abe; Hiroteru Kamimura; Akira Sakamaki; Kenya Kamimura; Atsunori Tsuchiya; Masaaki Takamura; Shuji Terai
Journal:  Cancer Manag Res       Date:  2018-07-25       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.